HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

被引:217
作者
Kaul, R
Trabattoni, D
Bwayo, JJ
Arienti, D
Zagliani, A
Mwangi, FM
Kariuki, C
Ngugi, EN
MacDonald, KS
Ball, TB
Clerici, M
Plummer, FA
机构
[1] Univ Nairobi, Dept Med Microbiol & Community Hlth, Nairobi, Kenya
[2] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada
[3] Univ Milan, Cattedra Immunol, Milan, Italy
[4] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
关键词
Africa; HIV-1; resistance; commercial sex workers; genital tract; humoral immunity; cellular immunity; sexual behaviour;
D O I
10.1097/00002030-199901140-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Most HIV-1 transmission is sexual; therefore, immune responses in the genital mucosa may be important in mediating protection against HIV infection. This study examined HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan female sex workers. Methods: HIV-1-specific immune responses were compared in HIV-1-resistant and HIV-1-infected sex workers, and in lower risk uninfected women. Cervical and vaginal samples from each group were tested for HIV-1-specific IgA and Ige by enzyme immunoassay. Systemic T-helper lymphocyte cell responses to HIV-1 envelope peptide epitopes were assayed using an interleukin 2 bioassay. HIV-1 risk-taking behaviours were assessed using standardized questionnaires. Results: HIV-1-specific IgA was present in the genital tract of 16 out of 21 (76%) HIV-1-resistant sex workers, five out of 19 (26%) infected women, and three out of 28 (11%) lower risk women (P < 0.0001). Among lower risk women, the presence of HIV-1-specific IgA was associated with HIV-1 risk-taking behaviour. Systemic T-helper lymphocyte responses to HIV-1 envelope peptides were present in 11 out of 20 (55%) HIV-7-resistant women, four out of 18 (22%) infected women, and one out of 25 (4%) lower risk women (P < 0.001). T-helper lymphocyte responses did not correlate with the presence or titre of virus-specific mucosal IgA in any study group. Conclusions: HIV-1-specific IgA is present in the genital tract of most HIV-1-resistant Kenyan sex workers, and of a minority of tower risk uninfected women, where it is associated with risk-taking behaviour. These data suggest a role for mucosal HIV-1-specific IgA responses in HIV-1 resistance, independent of host cellular responses. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 31 条
[1]   Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information [J].
Artenstein, AW ;
VanCott, TC ;
Sitz, KV ;
Robb, ML ;
Wagner, KF ;
Veit, SCD ;
Rogers, AF ;
Garner, RP ;
Byron, JW ;
Burnett, PR ;
Birx, DL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) :265-271
[2]   IN-VITRO PRODUCTION OF TYPE-1 AND TYPE-2 CYTOKINES BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIGH-RISK HIV-NEGATIVE INTRAVENOUS-DRUG-USERS [J].
BARCELLINI, W ;
RIZZARDI, GP ;
VELATI, C ;
BORGHI, MO ;
FAIN, C ;
LAZZARIN, A ;
MERONI, PL .
AIDS, 1995, 9 (07) :691-694
[3]   ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS IN VAGINAL SECRETIONS OF HETEROSEXUAL WOMEN [J].
BELEC, L ;
GEORGES, AJ ;
STEENMAN, G ;
MARTIN, PMV .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03) :385-391
[4]   INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
BERNSTEIN, DC ;
MANN, DL ;
SHEARER, GM ;
BERZOFSKY, JA .
NATURE, 1989, 339 (6223) :383-385
[5]   CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1 [J].
CLERICI, M ;
GIORGI, JV ;
CHOU, CC ;
GUDEMAN, VK ;
ZACK, JA ;
GUPTA, P ;
HO, HN ;
NISHANIAN, PG ;
BERZOFSKY, JA ;
SHEARER, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1012-1019
[6]   DEVELOPMENT OF OLIGONUCLEOTIDE PRIMERS AND PROBES AGAINST STRUCTURAL AND REGULATORY GENES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND THEIR USE FOR AMPLIFICATION OF HIV-1 PROVIRUS BY USING POLYMERASE CHAIN-REACTION [J].
DAWOOD, MR ;
ALLAN, R ;
FOWKE, K ;
EMBREE, J ;
HAMMOND, GW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) :2279-2283
[7]   Prevention of HIV infection in developing countries [J].
dCruzGrote, D .
LANCET, 1996, 348 (9034) :1071-1074
[8]  
DUNAND VA, 1997, 1997 KEYST S AIDS PA
[9]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IGA ANTIBODY IN BREAST-MILK AND SERUM [J].
DUPRAT, C ;
MOHAMMED, Z ;
DATTA, P ;
STACKIW, W ;
NDINYAACHOLA, JO ;
KREISS, JK ;
HOLMES, KK ;
PLUMMER, FA ;
EMBREE, JE .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :603-608
[10]   HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced β-chemokine production [J].
Fowke, KR ;
Dong, T ;
Rowland-Jones, SL ;
Oyugi, J ;
Rutherford, WJ ;
Kimani, J ;
Krausa, P ;
Bwayo, J ;
Simonsen, JN ;
Shearer, GM ;
Plummer, FA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (17) :1521-1530